CME/CE INFORMATION

Jointly provided by Postgraduate Institute for Medicine and Talem MedEd:

ACKNOWLEDGEMENT
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. 

Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS educational requirements issued by the US Food and Drug Administration.

This program fulfills West Virginia's 3-Hour Drug Diversion Training and Best Practice Prescribing of Controlled Substances Training requirement. Please check with your board to determine whether this activity will fulfill your state's requirements.

TARGET AUDIENCE
This activity is designed specifically for primary care clinicians, registered nurses, advanced practice registered nurses, pharmacists, and other members of the healthcare team.

LEARNING OBJECTIVES

• Discuss strategies and services needed to improve the care and management of pain
• Identify risk factors and behaviors associated with opioid use disorder and connect patients with appropriate support or treatment
• Describe the components of a comprehensive treatment plan including goals of therapy, periodic assessment and monitoring, and interdisciplinary team care and referral
  
• Summarize how to safely initiate therapy, modify the dosage, and discontinue use of opioid analgesics
• Compare and contrast pharmacologic and non-pharmacologic methods to manage pain
• Utilize appropriate tools to assess treatment response, adverse events, adherence, and signs of aberrant drug-related behaviors
• Educate patients on the proper use, storage, and disposal of opioids

FACULTY

Michael J. Brennan, MD
Medical Director, Pain Center of Fairfield
Fairfield, CT
Senior Attending Physician, Department of Medicine, Physical Medicine, and Rehabilitation
Bridgeport Hospital
Bridgeport, CT

Jeffrey A. Gudin, MD
Professor of Anesthesiology, Perioperative Medicine, and Pain Management
University of Miami, Miller School of Medicine
Miami, FL

Dana E. King, MD (Moderator)
Chair and Professor of Family Medicine
West Virginia University School of Medicine
Morgantown, WV

Erica L. Rusie, PharmD (Moderator)
Vice President, Scientific Affairs
Talem Health
Trumbull, CT

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Talem MedEd. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

• Part 1: Understanding the Fundamentals of Pain – 1.25 AMA PRA Category 1 Credit(s)^™
• Part 2: Best Practices for Prescribing Opioids in Primary Care – 1.25 AMA PRA Category 1 Credit(s)^™
• Part 3: Opioid Risk Evaluation, Mitigation, and Management – 1.25 AMA PRA Category 1 Credit(s)^TM

ABIM MOC Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

• Part 1: Understanding the Fundamentals of Pain – 1.25 ABIM MOC Points
• Part 2: Best Practices for Prescribing Opioids in Primary Care – 1.25 ABIM MOC Points
• Part 3: Opioid Risk Evaluation, Mitigation, and Management – 1.25 ABIM MOC Points

For physicians claiming ABIM MOC points, your information will be shared through the ACCME’s Program and Activity Reporting System (PARS). Please allow approximately 30 days for your MOC points to appear on your ABIM records.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.75 contact hours. Designated for 2.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

• Part 1: Understanding the Fundamentals of Pain – 1.25 Contact Hours
• Part 2: Best Practices for Prescribing Opioids in Primary Care – 1.25 Contact Hours
• Part 3: Opioid Risk Evaluation, Mitigation, and Management – 1.25 Contact Hours

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 3.75 contact hour(s) (0.375 CEUs) of the Accreditation Council for Pharmacy Education.

• Part 1: Understanding the Fundamentals of Pain – 1.25 Contact Hours
• Part 2: Best Practices for Prescribing Opioids in Primary Care – 1.25 Contact Hours
• Part 3: Opioid Risk Evaluation, Mitigation, and Management – 1.25 Contact Hours

(Part 1 Universal Activity Number - JA4008162-9999-21-168-L05-P)
(Part 2 Universal Activity Number - JA4008162-9999-21-169-L05-P)
(Part 3 Universal Activity Number - JA4008162-9999-21-170-L05-P)
Type of Activity: Application

DISCLOSURES OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine and Talem MedEd adhere to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Postgraduate Institute for Medicine requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to Postgraduate Institute for Medicine policy. Postgraduate Institute for Medicine is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Faculty
Michael J. Brennan, MD, has disclosed the following relevant financial relationships: speaker fees from BioDelivery Sciences International, Inc., RedHill Biopharma Ltd., and SCILEX Pharmaceuticals, Inc.

Jeffrey A. Gudin, MD, has disclosed the following relevant financial relationships: consultant for BioDelivery Sciences International, Inc., Hisamitsu Pharmaceutical Co., Inc., Quest Diagnostics, Sanofi, SCILEX Pharmaceuticals, Inc., and Verséa; and ownership interest in Virpax Pharmaceuticals.

Dana E. King, MD, has no relevant financial relationships to disclose.

Erica L. Rusie, PharmD, has no relevant financial relationships to disclose.

Planners, Managers, and Reviewer
The Talem MedEd and Postgraduate Institute for Medicine planners, managers, and reviewer have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

MEDIA
Internet activity

COMPUTER SYSTEM REQUIREMENTS

• System checker: Must meet all requirements of Digitell Live Events Platform
• Operating system: Windows or Macintosh
• Supported browsers: HTML5-capable browser – Internet Explorer, Google Chrome, Mozilla Firefox, Safari, Microsoft Edge, Opera
• Hardware: computer, smartphone, or tablet
• Broadband Internet connection: high-speed connection preferable

FEE INFORMATION
There is no fee for this educational activity.

CONTACT US
General Questions
For general information or questions about this activity, please contact Talem MedEd at 800-913-9370 or cme@talemcme.com.

Accreditation Support
For questions regarding the certification of this activity, please contact Postgraduate Institute for Medicine at inquiries@pimed.com.

©Talem MedEd, a division of Talem Health, LLC 2022. All Rights Reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Talem Health, LLC is prohibited.